Follow-up assessment of women suffering from cervical uterine cancer in two polyclinics, Pinar del Rio
Keywords:
Uterine cervical neoplasms/diagnosis/therapy/mortality.Abstract
Introduction: Despite of having a program, for a long time, to the early detection of cervical uterine cancer, the results expected are not as far achieved.
Objective: to characterize the patients suffering from invasive cervical uterine cancer in two health areas in Pinar del Rio province throughout five years (2003-2007).
Material and Methods: observational, cross-sectional, cohort, retrospective study including women at every age with invasive cervical-uterine cancer. The information concerning the patients was collected from the automated records of cervical uterine at the provincial office for cervix pathology treatment (Provincial Public Health Direction), general death rate (Provincial Public Health Direction) and from the clinical histories of the Provincial Cancer Unit. Among the variables studied were: coming or not from the program, age, clinical stage, treatment followed, and annual incidence, together with the average of mortality and lethality considering the clinical stages.
Results: 70,6% of the cases were not detected by the program. The average incidence rate was 29.5 per 10 0000 women from 15 years old or older. All patients underwent to a specific cancer treatment according to the clinical stage. The greatest mortality rates were found in patients presenting IIIB stage at diagnosis.
Conclusion: errors were observed in Primary Health Care leading to deficiencies in the early detection of this type cancer. The incidence rates of this disease have not diminished; cases suffering from advanced stages of the disease are still detected, shortening the survival rate of these patients.
Downloads
References
1. Agrawal P. Reducing the burden of cervical cancer in the developing world. Current Women´s Health Reviews feb 2011; 7(1):59-68. Disponible en: http://www.ingentaconnect.com/content/ben/cwhr/2011/00000007/00000001/art00011 [Access 22-04-11]
2. Schiffman M, Kjaer SK. Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia. J Nat Cancer Inst Monogr 2003;(31):14-19. Disponible en: http://jncimonographs.oxfordjournals.org/content/2003/31/14.long [Access 25-04-11]
3. Tábora N, Ferrera A, Bakkers JMJE, Massuger L FAG, Melchers WJG. High HPV 16 Viral Load is Associated with Increased Cervical Dysplasia in Honduran Women. Am. J. Trop. Med. Hyg., 78(5), 2008, pp. 843-846 In: http://www.ajtmh.org/content/78/5/843.long [Access 21-12-08]
4. Alam S, Conway MJ, Chen HS, Meyers C. The cigarette smoke carcinogen benzo a pyrene enhances human papillomavirus synthesis. J Virol 2008 Jan, 82 (2): 1053-1058. In: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2224590/. [Access 21-12-08]
5. Bonassi S, El-Zein R, Bolognesi C, Fenech M. Micronuclei frequency in peripheral blood lymphocytes and cancer risk: evidence from humand studies. Mutagenesis 2010; 26 (1): 93-100. In: http://mutage.oxfordjournals.org/content/26/1/93.full [Access: 21-12-08]
6. Denis F, Hanz S, Alain S. Clearance, persistence and recurrence of HPV infection. GynecolObstetFertil. 2008 Apr;36(4):430-40. En: http://www.ncbi.nlm.nih.gov/pubmed/18417407. [Access 13-06-08]
7. Monsonego J. Prevention of cervical cancer (II): prophylactic HPV vaccination, current knowledge, practical procedures and new issues. Presse Med. 2007 Apr;36(4 Pt 2):640-66. In: http://www.ncbi.nlm.nih.gov/pubmed/17350792. [Access 26-09-2007]
8. Franco EL, Cuzick J. Cervical cancer screening following prophylactic human papillomavirus vaccination.Vaccine. 2008 Mar 14;26Suppl 1:A16-23. In: http://www.sciencedirect.com/science/article/pii/S0264410X07013849 [Access 26-09-2007]
9. Arbyn M, Primic-Zakeus M, Raifu AO, Grce M, Paraskevaidis E, Diakomanolis E, Kesiæ V, Nicula FA, Suteu O, von Karsa L. The burden of cervical cancer in south-east Europe at the beginning of the 21st century.CollAntropol. 2007 Apr; 31 Suppl 2:7-10. In: http://www.hrcak.srce.hr/.pdf. [Access: 26-08-07]
10. Brawley OW. Avoidable cancer deaths globally.CA Cancer J Clin 2011; 61: 67-68. In: http://onlinelibrary.wiley.com/doi/10.3322/caac.20108/full [Access 14-06-2011. ]
11. MINSAP. Cuba. Programa de Detección Precoz del Cáncer Cérvico-Uterino. 2001.
12. Flores BP, Volker DL. Cervical cancer screening and older Mexican American women. Res GerontolNurs 2011 Jan; 4 (1): 3-8. doi: 10.3928/19404921-20101201-04. In: http://preview.ncbi.nlm.nih.gov/pubmed/21210574. [Access 30-05-11]
13. Xi LF, Hughes JP, Castle PE, Edelstein ZR, Wang C, Galloway DA, Koutsky LA, Kiviat NB, Schiffman M. Viral load in the natural history of HPV Type 16 infection: a Nested case-control study. J InfectDis 2011;203:1425-33 In: http://www.jid.oxfordjournal.org [Access 16-04-11]
14. Belinson, J.L., Pretorius, R.G., Zhang, W.H., Wu, L.Y., Qiao, Y.L., and Elson, P. Cervical cancer screening by simple visual inspection after acetic acid. Obstetrics and Gynecology 2001 Sep; 98(3):441-444. In: http://www.ncbi.nlm.nih.gov/pubmed/11530126. [Access 22-05-07]
15. Sanabria NegrinJG, Salgueiro Medina VE, Abreu Mérida MB, Vólquez C. Incremento de la detección de las lesions cervicales por medio del examen visual en Puerto Esperanza, , 2008. Rev Ciencias Médicas [revista en la Internet]. 2011 Sep [citado 2011 Dic 18]; 15(3): 81-98. In: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-31942011000300009&lng=es
16. Kirschner B, Poll S, Rygaard C, Wåhlin A, Junge J. Screening history in women with cervical cancer in a Danish Populaton-based screening program.GynecolOncol 2011 Jan, 120 (1): 68-72. In: http://web.ebscohost.com/ehost/21035171. [Access 15-04-11]
17. Cantor SB, Cárdenas-Turanzas M, Cox DD, Atkinson EN, Nogueras-González GM, Beck JR, Follen M, Benedet JL. Accuracy of colposcopy in the diagnostic setting compared with the screening setting. ObstetGynecol. 2008 Jan;111(1):7-14. In: http://www.sggg.ch/files/Garland2007intrabib30004.pdf [Access 01-04-08.]
18. Castro-Jiménez MA, Londoño-Cuellar PA, Vera-Cala LM. Uso y determinantes del Papsmear en un municipio rural de Colombia 1998-1999. Rev Salud Pública (Bogotá). 2006 Sep-Dic; 8 (3): 248-57. In: http://www.scielosp.org/scielo.php?pid=S0124-00642006000300010&script=sci_arttext&tlng=pt [Access 24-01-07]
19. Davey DD, Cox JT, Austin RM, Birdsong G, Colgan TJ, Howell LP, Husain M, DarraghTM.Cervical cytology specimen adequacy: patient management guidelines and optimizing specimen collection. J Low Genit Tract Dis. 2008 Apr; 12(2):71-81 In: http://journals.lww.com/jlgtd/Abstract/2008/04000/Cervical_Cytology_Specimen_Adequacy__Patient.2.aspx. [Access 26-06-08]
20. Cucick J Routine audit of large-scale cervical cancer programs. Editorial JNCI; 2008 May 7; 100 (9):604-6. In: http://jnci.oxfordjournals.org/content/100/9/605.full [Access 20-07-2008]
21. Andrae B, Kemetli L, Sparén P, Silfverdal L, Strander B, Ryd W, Dillner J, Törnberg S. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J NatlCancer Inst. 2008 May 7;100 (9):622-9. In: http://jnci.oxfordjournals.org/content/100/9/622.full [Access 25-7-08]
22. Galán Y, Fernández L, Torres P, García M. Trends in Cuba's Cancer Incidence (1990 to 2003) and Mortality (1990 to 2007).MEDICC Review, Summer 2009, 11 (3): 19-26. In: http://www.medicc.org/mediccreview/index.php?issue=9&id=101&a=va [Access 31-07-2009]

Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/